- Understanding Fetal Alcohol Syndrome: A Persistent Global Issue
- Reprogrammed Immune Cells Offer Hope in the Fight Against Glioblastoma
- Immuno Throwback – The Complex Relationship Between COVID-19 and Kidney Disease: A Closer Look
- Disease-Modifying Immunotherapy in Type 1 Diabetes
- CD47 – new insights into treatment of colorectal cancer
- Guardian Peptides Key to Balancing Defense and Protection in Neuroinflammatory Diseases
- The Immunological Landscape of Kidney Disease: Insights and Innovations
- Insights: CD4+ T Cell Tolerance and Autoimmunity
- Dual Role of the GID Complex in Cancer and Tuberculosis Opens Doors to Novel Therapies
- Understanding SARS-CoV-2’s Enzyme: A Key to Its High Infectivity and Potential Treatments
- Immuno Throwback – Resident Memory T Cells and Cancer Immunity
- Novel Alveolar Macrophage Model Sheds New Light on Tumor Necrosis Factor’s Role in Tuberculosis
- Microbial Survival Strategies in Extreme Environments
- Prediction of disease – using immune signatures
- Mechanisms of GBP1: A Key Protein in the Body’s Defense Against Bacterial Infections
- Immuno-Throwback: Herpes Simplex Virus-1 in the Brain
- Novel insights into organ transplant rejection
- Nanotube-Mediated Mitochondrial Transfer: Enhancing T Cell Power Against Cancer
- A New Study Underscores the Importance of Breastfeeding for Infant Health
- Immuno Throwback – The Neuroimmunology of Chronic Stress
- A New Frontier in Autoimmunity: The Role of Neoself-Antigens
- The Eye’s Immune Defense: A New Perspective
- Immuno Throwback – Advances in Cutaneous T-cell Lymphoma Research
- Fever’s Double-Edged Sword: A Cellular Perspective
- The Itch Behind Allergies: A New Understanding
- Disease-specific Transcriptional Programs Govern Airway Goblet Cell Hyperplasia in Asthma and Cystic Fibrosis
- Acute Kidney Injury (AKI): A Role for Macrophage Lipid Mediators
- Childhood Immunisation Holds Promise for HIV Prevention
- Immuno Throwback – Role of Inflammatory Cytokines TNF-α and IL-17 in the Pathogenesis of Disease
- A New Pathway to Skin Health
- T Cells and Innate Immune Memory
- Immunology Throwback – Effects of Airway Surface Liquid pH on Host Defence in Cystic Fibrosis
- Gut Microbes and the Development of Allergies: A New Understanding
- Immunology Throwback – Roles of Antimicrobial Peptides in Airway Mucosa and Cystic Fibrosis
- New insights – Proteomic aging and age-related diseases
- A Novel Approach to Combat Heart Transplant Rejection
- Immune Suppression in Chronic Hepatitis B: A Novel Mechanism
- Celiac Disease: novel breakthrough!
- A Potential Breakthrough in Long COVID Treatment
- Maternal Influenza and Fetal Neurodevelopment
- Insights into immune evasion by respiratory bacteria
- Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy
- Engineered B Cells: A New Frontier in Immunotherapy
- Organoid models elucidate Celiac disease pathogenesis
- Insights into the immunological roots of stroke
- Unveiling Biomarkers for COVID-19 Outcomes
- Emerging Biomarkers in HIV Care: The Role of Platelet Index Ratios
- New insights – Spatiotemporal control of necroptosis
- Exercise Boosts Cancer-Fighting Immune Cells in Breast Cancer Patients
- T Cells Take Aim at Merkel Cell Carcinoma
- A New Hope in HIV Vaccine Development: Targeting Broadly Neutralizing Antibodies
- New Research Sheds Light on Lupus Pathogenesis
- Potential Treatment for Ulcerative Colitis: Targeting Stem-like T Cells
- New Hope for Personalised Treatment of Neuromyelitis Optica
- How Hepatitis E Evades the Immune System and Becomes Chronic
- Fat Fighters: How Macrophages Link Obesity and Cancer Treatment
- Fasting Might Boost Your Body’s Natural Cancer Fighters: New Study in Mice
- Muscle Mend: Macrophages Morph to Heal After Injury
- Placental Clues: Monitoring Fetal Brain Development
- Does pre-TCRα deficiency have any effect on human beings?
- What dose of SARS-CoV-2 is safe enough to induce infection in seropositive individuals?
- Heart Failure’s Hidden Culprit: How It Alters Stem Cells and Fuels Disease
- Epstein-Barr Virus: Targeting Metabolism to Curb Cancer Risk
- Eosinophils: Unveiling the Mysteries of These Immune Cells
- News Insight – Bystander neutrophils and Mtb infection
- C-Section and Measles Vaccine: One Dose May Not Be Enough
- Melanoma: New Blood Test Predicts Response to Immunotherapy
- Dirty Air and Altered Genes – Risks for infants
- AI Paves the Way for Personalized Cancer Immunotherapy with Powerful T Cell Selection
- Gut Microbiome Harmony in Dads May Be Crucial for Healthy Offspring: New Study in Mice
- Scientists gain insights into TLR7
- Engineered Off-the-Shelf Cells Offer New Hope for Glioblastoma Treatment
- Negatives After Stroke or Heart Attack – Increased Infection Risk and Potential Treatments
- A Weapon Against Superbugs: Promising New Vaccine Candidate Emerges
- New Hope for Treatment-Resistant Lyme Disease: Targeting Inflammation
- Never Too Early to Exercise: Long-Term Benefits of Early Life Exercise
- Hidden Sugars: Unveiling a Link Between HIV and Accelerated Aging
- New Hope for Chronic Hepatitis B: Boosting T Cell Power
- New Blood Test May Help Diagnose and Treat Long COVID
- Alzheimer’s Breakthrough: Microglia Power Up to Clear Harmful Plaques
- Mapping the Gut: A New Tool Unveils Secrets of Inflammation
- A New Twist in the COVID’s story: Antibodies Gone Rogue
- Psoriasis: new insights into potential treatment
- New Hurdle for CAR T-Cell Therapy in Aggressive Blood Cancer
- Baby Gut Bacteria: Serotonin Powerhouse for Early Immunity!
- New Hope for a Type 1 Diabetes in Liposome Therapy
- Immune cells of the liver – fighting cholesterol
- Exciting New Target Discovered for Epstein-Barr Virus
- Sleep can strengthen your immune response
- New Hope for Cervical Cancer – A Promising Therapy
- Beyond a Window: Eyes Emerge as Brain’s Immune Defenders
- Interfering with T cell help: IFN-β for Enhanced Anticancer Immunity
- Baby Power: Surprising Strength of Newborn Immune Systems
- A Glimpse into the Future of HIV Treatment
- CAR T-cell therapy – a potential treatment for autoimmune diseases
- Alzheimer’s: new insights found in our blood and the immune system
- Smoking’s Shadow: How It Alters Your Immune System Even After Quitting
- Stressful Signals: How Your Body Talks to Your Brain
- Atypical B Cells: Unsung Heroes in the Fight Against Malaria
- How T cells combat tuberculosis
- Impacts of diet choice on your immune system
- Interrogation of the T cell landscape in pediatric brain tumors
- Breast milk – immune insights
- Using AI for immunotherapy
- Long COVID and complement activation
- Remodelling of alveolar macrophages to combat Mycobacterium infection
- Guillain-Barré syndrome – new insights
- Cytokine storm – insights into new treatments
- Inflammation and ALS – inhibition to reduce symptoms
- The gut microbiome and inflammation – new insights
- Breath of life – immune insights
- Fat cells and tumour growth
- The role of JAK inhibitors in inflammation – new insights
- Vaccine development – new insights from epitopes
- Advancements in CAR T-Cell Therapy: A Promising Clinical Outlook
- The battle against Herpes – insights
- Unveiling Zika Virus’ Multi-Purpose Enzyme: A Potential Therapeutic Target
- Inflammaging – new insights
- New insights: hypertension-induced dementia
- Accelerating Tuberculosis Vaccine Development: Insights from BCG Studies
- Novel immune cells unveil potential trigger for severe asthma
- Food allergies and cardiovascular health
- Reprogramming Brain’s Defense Cells into Neurons Aids Stroke Recovery
- Key immune threshold identified for SARS-CoV-2
- Unlocking the secrets of the thymus: a window into immune system aging
- AI and vaccine development for gonorrhea
- A sugar-enzyme link to tumour growth suppression
- Mycobacterium tuberculosis – cord formation and antibiotic resistance
- Mycobacteria have an albumin binding capacity – possible implications
- Prior exposure to common virus may protect the fetus
- Cytomegalovirus – new insights into immune protection
- New technique for targeted immunotherapy shows promise in mice
- New insights into mosquito-to-human viral transmission
- A Hidden Haven: how Leishmania parasites hide in our cells
- A new protein may be key in placental heath
- Elders’ vs new-borns and children – insights into immune phenotypes
- New imaging agent – improved prediction of HER2 positive metastatic breast cancer
- Triple-negative breast cancer – a potential treatment on the horizon
- Enhancing B Cell Memory: The Role of Autophagy and the RUBCN Protein
- Cracking the Code of Implant Rejection – new insights
- Neutrophils – new insights for clinical studies
- Maternal immunity: how mothers “remember” their babies and understanding pregnancy pathology
- A link: Atopic Dermatitis and Inflammatory Bowel Disease
- Antibody diversity – new insights
- New biomarker for vascular dementia
- Our immune system…in space
- kidney-on-a-chip – cancer and immune insights
- Malaria vaccine – positive results within a Tanzanian cohort
- Severe COVID-19 may change your innate immune system
- Using immune cells to predict flu
- Human-derived 3D model for Alzheimer’s disease – immune insights
- Evaluating a Peptide-Based T-Cell Activating COVID-19 vaccine – Insights from a Phase I/II Trial
- Parkinson’s disease – new insights into immune cell landscape
- Using a virus to treat Pancreatic Cancer
- More robust immune systems in children from rural areas
- Mapping macrophage diversity in liver diseases
- T cells and type 1 diabetes prevention
- The potential of T cell activation markers for TB diagnostic development
- The landscape of human cornea – immune cells
- Immunoregulation in the brain – new insights
- Mitchondrial disorder linked to a weaker immune response
- Allergen sensitization – insights into atopic dermatitis and other skin disorders
- Key discovery in our battle against HIV
- MS, inflammation and the brain – new insights
- How melanoma evades the immune system
- B cells and PCOS
- Single-cell RNA sequencing – new insights into cancer
- New insights into inflammation
- How metabolic rewiring influences macrophage function
- Early loss of a parent may impact our immune systems
- Lupus and the microbiome – the flare
- Anti-tumour T-cell activation from B-cells
- Making cancer immunotherapy safer
- Genetics and allergies
- Placental protection of the fetus – new insights
- Respiratory Syncytial Virus (RSV) infection – the role of T cells
- The immune system during old age
- Skin aging – IL-17 a role player
- Harmful blood in the brain – immune insights
- Autoantibodies in Systemic Autoimmune Diseases
- Stress mediated stirring up of the immune system
- New insights – drug resistance malaria
- Decoding HIV – insights from an animal model
- Smallpox vaccine for mpox?
- Single cell profiling at the maternal–fetal interface – insights
- A skin patch for peanut allergy
- A positive sign for prostate cancer treatment
- Inflammatory bowel disease – mapping the immune system of the gut
- TB and HIV – an enhanced antibody response
- Modelling the brain – new insights
- How some individuals with immunodeficiency defend themselves against infection
- Using gamma T cells to fight TNBC
- PSGL-1 regulates CD8+ T Cell Exhaustion
- Clear cell renal cell carcinoma – new “spatial,” insights
- Chronic transplant rejection – new insights
- Possible new treatment for rheumatoid arthritis
- Using lab grown organs to test vaccines
- Immunity in centenarians – keys to life?
- Improving pancreatic cancer therapy – insights
- The early stages of HIV infection – new insights
- Phosphatidylserine-positive extracellular vesicles – boosting effector CD8+ T cell responses
- Regulatory T cells – new insights
- How neutrophils can be used to fight cancer
- New insights into mechanisms of HIV infection
- Enhancing the immune system to fight TB infection
- COVID-19 and HIV – how antibody responses are affected
- The immune system and liver disease – new insights
- The immune system – new insights
- Is trained immunity impacted by revaccination or BCG dose?
- Inflammation in soft gums – insights
- The role of T cells in Alzheimer’s disease – novel insights
- COVID-19 – creating a vaccine that can change with the virus
- Eliminating metastatic breast cancer in mice – immunotherapy insights
- How immune cells fight chronic infection or disease – new insights
- Specific B cell targeting to treat lupus
- Why prematurely born babies are more susceptible to infection
- What drives allergic asthma? New insights
- First COVID-19 vaccination may affect booster shot efficacy
- Defining more roles for Natural Killer cells
- A potential cure for HIV may exist in stem cell transplantation – however…
- Priming the immune response with ginger
- T-cell protection against pneumococcal disease
- Is salt bad for you? Starving immune regulators of energy
- Blocking SARS-CoV-2 infection – new insights
- T cell exhaustion- new insights
- Do your genetics make you more susceptible to infections?
- New TB drug regimen may not work against TB meningitis
- Epstein-Barr virus – novel insights into the immune response to the virus
- Novel insights into the treatment of lupus
- COVID-19 and the innate immune system – long term effects
- Immune response diversity driven by B cells
- Understanding gut inflammation using caterpillars
- Vaccines and respiratory viruses
- Insights into the mechanism lung cancers use to evade the immune system
- Newly discovered IFN-γ role in Metabolic reprogramming to support Tumor Evasion
- A vaccine for brain cancer?
- COVID-19 vaccination may offer cancer protection
- Novel therapy to reduce immune rejection of transplant cells
- Why we lose our smell – COVID-19
- Insights into the regulation of inflammation
- Blood clotting – insights into sepsis
- Respiratory infections – common (in) cold (temperatures)
- Your gut microbiome and white blood cells
- Leukemia linked T cells may drive autoimmune diseases
- Predicting patient responses to COVID-19 immunotherapies
- Neurological effects of COVID-19
- HIV and its mechanisms of drug evasion
- Axon regeneration in the adult nervous system – immune modulation
- Atypical B cells as biomarkers of renal complication in lupus patients
- Improved cancer treatment response in those with COVID vaccination
- Tumor associated macrophages: the future targets for anti-melanoma immunotherapy ?
- Novel insights – regulating skin inflammation
- Vimentin and its role in COVID-19 infection
- How the brain slows us down when we are sick
- Improving vaccine immunity against fungal pneumonia
- Time of day for COVID-19 vaccination does not matter
- Non-invasive tumour immune cell monitoring
- Infection in the brain – defenses and consequences
- What determines COVID-19 disease persistence and severity?
- Novel treatment approach for asthma without negative immune system effects
- Development and use of cellular behavioural landscapes to describe inflammatory states
- The interplay between LRRC15+ myofibroblasts and anti-tumour immunity
- The opportunity to boost antiretroviral therapy interventions through maternal vaccination
- Rebound to COVID-19 – not from impaired immunity
- The humoral response as a marker in patients with chronic obstructive pulmonary disease
- How to boost immunotherapies against B-cell leukemia
- SARS-CoV-2 can infect adipose tissue
- Lack of sleep and your immune system
- What effect does anti PD-1 therapy have on responses to the influenza vaccine?
- Vaccine-associated enhanced respiratory disease in hamsters vaccinated against COVID-19
- Increased activity of Neutrophil Elastase in sera of SLE patients during the COVID-19 pandemic
- Inhibiting Mycobacterium tuberculosis infection
- SARS-CoV-2 infection following vaccination – more robust immunity
- Novel protein linked to rheumatoid arthritis pathogenesis
- Using viruses to fight cancer
- Antibodies from cows may provide protection from Mycobacterium avium subsp. paratuberculosis
- A ‘side-ways’ mechanism of detection in CD1a and γδ T cell receptor interactions
- Neutrophils as biomarkers for COVID-19 and recovery
- What does HIV infection have to do with T follicular regulatory cells (TFRs)?
- What role do CD137L and CD4 T-cells have in B-cell lymphoma immuno-surveillance?
- Blocking of an important coronavirus enzyme with natural compounds
- Helminths and Vaccine responses
- A map of the immune system
- CD8 T-cell mediated vaccine protection against SARS-CoV-2
- The emergence of inflammatory monocytes as the leukemia anteroom.
- New insights into the interferon response to SARS-CoV-2
- Distinct antibody responses as biomarkers to monitor cancer immunotherapies
- Promising new insights: the immune response following a stroke
- IL-25 blockade as a therapeutic strategy for asthma
- Using bacteria to fight cancer
- Unique genes: the innate immune response and tuberculosis
- SARS-CoV-2 Omicron variant in hamsters is not as deadly as we think
- Nasal spray immunisation: potential use against HIV and SARS-CoV-2 shown in an animal models
- Cancer, collagen the microbiome and immunity – a link!
- COVID-19 and the brain – new insights
- Can reprogramming CD8 T-cells contribute to a cure for a HIV?
- An inflammatory pathway linked to autoimmune diseases
- Developing new tools to combat COVID-19
- SARS-CoV-2 omicron variant hardly evade neutralization by S309
- Hair growth and our immune system
- SARS-CoV-2 – a weakness?
- The immune system and obesity
- Adaptations of tissue-resident memory T cells
- Using lipid nanoparticles for cancer treatment
- A vaccine with a dual threat to cancer
- Can BCG vaccination reduce mortality and morbidity from COVID-19?
- A potential new vaccine for rabies
- Does cancer immunoediting occur in humans?
- What happens to your cilia during SARS-CoV-2 infection?
- T cell lineage fate is driven by CD4 and CD8 co-receptor gene loci
- Novel insights: immunotherapy responses in lung cancer
- Comparing four COVID-19 vaccines
- Does the timing of granuloma formation affect TB control?
- ATLAS – describing SARS-CoV-2 variant T-cell responses
- Human M1 macrophages champion the control of TB disease
- Cannabidiol – a potential tool for fighting SARS-CoV-2
- Improving Chagas disease diagnosis and treatment
- Bifonazole – a potential treatment for SARS-CoV-2 infection
- Immunodiagnostic of onchocerciasis: do we have the right tool to end the game?
- Stopping inflammation in its tracks
- T cells and melanomas – a potential predictive tool
- COVID-19 mortality and genetic predisposition
- Novel vaccines induce neutralising antibodies against Epstein-Barr virus in mice
- SARS-CoV-2 and partial resistance to remdesivir
- Enhancing the immune response: skin bacteria and the smallpox vaccination
- Leaky gut in COVID-19 and its impact on Neutrophil Extracellular Trap formation
- Where is single cell genomics taking the field of Immunology?
- TB diagnosis in children: metabolite biomarkers
- Atopic dermatitis and the skin microbiome
- Improving treatments for autoimmune diseases
- Developing monoclonal antibodies against SARS-CoV-2
- TB treatment with diabetes comorbidity: new insights
- SARS-CoV-2 and T-cell escape
- B cell signalling deficiencies – new insights into treatments
- SARS-CoV-2 and mucosal immunity
- The role of the PD-1 blockade in Mycobacterium tuberculosis infection
- Sugar and autoimmune diseases: what are the risks?
- B-cell immunity against SARS-CoV-2 in unexposed individuals
- Enhanced production of effective and personalised vaccines for cancer
- COVID-19: antigen-specific T cell response and immuno-metabolomic signatures
- Biomarkers to identify Mycobacterium tuberculosis-infection: finding the needle in a haystack
- T cells and skin disease
- B-cell immunity following SARS-COV-2 mRNA vaccination – 6 months on…
- A potential mRNA vaccine for SARS-CoV-2 Omicron variant
- More than a gut feeling: The implication of gut microbiota in the pathology of Alzheimer’s Disease
- MAIT cells – a new target for future immunotherapies and vaccines
- Immune memory in the intestine: new insights into “innate memory”
- A new tool fight SARS-CoV-2: an ACE2-blocking antibody
- Novel HIV-1 variant found in Netherlands: the implications
- Understanding the immune system and COVID-19: New insights
- Ovarian cancer and immune evasion
- A new TB vaccine – is it cost-effective and efficient?
- More SARS-CoV-2 variants?
- HIV vaccine progress
- A nanoparticle based vaccine for SARS-CoV-2 neutralization and protection
- Predicting transplant rejection using proteoforms
- Epstein-Barr Virus found to trigger Multiple Sclerosis
- Treatment with interferon-λ confers protection from SARS-CoV-2 variants – Beta and Omicron
- Th17 and Multiple Sclerosis (MS)
- A potential end to peanut allergies?
- Why is SARS-CoV-2 Omicron less severe than Delta?
- A new target for TB treatment with great potential
- Formation of tertiary lymphoid tissue: fighting chronic inflammation
- Our natural defence to skin cancer – new insights
- Can we use cannabinoids to block SARS-CoV-2 viral entry?
- Toothpaste – a trigger for gut inflammation
- How do immune cells invade tissue?
- T-cell response to SARS-CoV-2 Omicron
- B cell lymphomas and the role of TET enzymes
- Changes in SARS-CoV-2 Omicron variant spike protein
- Resistance to key antimalarial drug?
- COVID-19 and idiopathic pulmonary fibrosis (IPF)
- Can fat help us combat infection?
- Antibody profile in response to SARS-CoV-2 – serological profile and specificity of maternal and neonatal cord blood
- Germline mutations in innate immunity associated with the risk for breast cancer: case of C-reactive protein
- New Insights into the diagnosis, prognosis and monitoring of Multiple Myeloma: What’s the role of the Heavy/Light Chain Assay?
- Antiretroviral therapy influences tumour development in patients with HIV
- Promotion of protective anti-tumour CD8+ T cell immunity – a new treatment for tumours
- Alzheimer’s Disease – a potential vaccine?
- Immune system evasion – the HIV-infected cell
- Improving existing malaria vaccines – new insights
- Detection of autoantibodies in patients with multisystem inflammatory syndrome in children (MIS-C)
- Immunotherapy – new insights into how CD8+ T cells become unresponsive to treatment
- Predicting response to immunotherapy in patients with clear cell renal cell carcinoma (ccRCC)
- Pregnancy and its influence on the immune response to SARS-CoV-2
- Toxoplasma gondii-Induced Neutrophil Extracellular Traps Activate Neutrophils and promote T cell recruitment
- Neutrophils as potential early indicators of tuberculosis severity
- Microbial fitness and IgA – a balancing act for the intestinal flora
- Malaria Vaccine Breakthrough: Shaking or Stirring the Field?
- A novel immunogene CD47-targeting therapy inhibiting tumour growth
- A novel inhibitor of dengue virus
- Variations in leukocytes – three months following mild COVID-19 infection
- Insights into the development of the blood and immune systems in prenatal bone marrow
- New hope – a potential new treatment for sepsis
- Identification of D6R and C5aR2 as key molecules with the potential to combat inflammatory diseases
- Microglial cells – immune cells of the CNS breaking down harmful proteins in the brain
- A new cell type contributing to inflammatory skin diseases
- How does vitamin A enter our intestinal immune cells and what are the implications?
- Neutrophilic aid – extracellular traps to enhance macrophage directed bacterial killing
- A new tool for predicting COVID-19 severity and prognosis
- Ad26.CoV2.S vaccine significantly boosts pre-existing SARS-CoV-2 specific antibodies but not CD4 T cell immune responses
- A potential new biomarker for Preeclampsia
- Reprogramming the Tumour Microenvironment – Improving Cancer Survival
- Does B.1.351 SARS-CoV-2 variant escape T cell immune responses?
- Neutrophil dominance leads to protection from P. falciparum blood-stage merozoites
- A novel pathway of immune and host cell evasion by Mycobacterium tuberculosis
- Pre-clinical evaluation of a vaccine that induces both SARS-Cov-2 and yellow fever virus immunity.
- Can neutrophils adopt antigen-presenting cell functions, and if so how?
- IUIS Webinar: HIV prevention- antibodies and vaccine development (part 2)
- IUIS Webinar: HIV prevention- antibodies and vaccine development (part 1)
- Potent neutralising antibodies against SARS-CoV-2 variants of concern.
- World Hepatitis Day: proof of concept HCV nanoparticle vaccine
- Immunogenicity of heterologous SARS-CoV-2 vector vaccine prime-mRNA vaccine boost vaccination strategy
- Global Immunotalks Highlight: Immune responses after dengue virus infection: friend or foe?
- What does HLA-DR expression on CD4 T cells indicate?
- IUIS-Immunopaedia-Frontiers Webinar: Immunopathology of COVID 19 lessons from pregnancy and from ageing
- Could infection with other viruses provide protection from SARS-CoV-2?
- Microbes prime foetal immune cells during early human development
- The role of emergent food allergies in rethinking vaccine strategies
- How Sickle-trait hemoglobin protects against severe Plasmodium falciparum malaria
- HIV-1 and TB coinfection skews the SARS-CoV-2 T cell response
- WNT7A: The new marker for resting T cells
- Does serial administration of HIV-specific VRC01 bnAbs prevent HIV acquisition?
- An update on the Shock and kill HIV cure strategy
- IUIS-Immunopaedia-Frontiers Webinar: Clinical representation of hyperinflammation
- IUIS-Immunopaedia-Frontiers webinar: In-depth characterisation of immune cells in Ebola virus.
- BCG reduces all-cause infectious diseases in the first 6 weeks of life in infants!
- IUIS-Immunopaedia-Frontiers webinar: Getting to the “bottom” of arthritis
- Immuno-Colombia: Overview of immunotherapy
- Immuno-Colombia: Therapeutic cancer vaccines
- Immuno-Colombia: Tumour infiltrating lymphocyte therapy (Part 2)
- Immuno-Colombia: Tumour infiltrating lymphocyte therapy (Part 1)
- Immuno-Colombia: MDSCs promote tumour growth and escape
- Immuno-Colombia: Anti-cytokine therapies (Part 2)
- Immuno-Colombia: Anti-cytokine therapies (Part 1)
- Immuno-Colombia: Checkpoint Blockade-based Therapies (Part 2)
- Immuno-Colombia: Checkpoint Blockade-based Therapies (Part 1)
- Exploring characteristics of COVID-19 to guide public health policies & therapeutic interventions.
- C5a-C5aR1 axis plays a role in cobra venom immunopathology.
- Antibody response to vaccination post-COVID-19 infection
- Aged Neutrophils support tumor metastasis
- P.falciparum secretes extracellular vesicles with functional 20S proteasomes to prime RBCs for parasite invasion
- Pregnant women show elevated levels of anti-inflammatory glycosylation patterns of IgG antibodies
- First report on Effectiveness of HPV Vaccination in LMICs – Rwanda and Bhutan
- Does ACE2 expression & cytotoxic lymphocyte levels indicate a risk factor for COVID-19?
- Immunopathogenesis of Autoimmune Hepatitis
- B1.351 (501Y.V2) induces cross-reactive Ab responses to other SARS-CoV-2 variants.
- IUIS-Immunopaedia-Frontiers Webinar on Immunology taught by P. falciparum
- Is tumour circulating DNA a better tool for cancer diagnostic and prognostic than immunological biomarkers?
- HPV & HIV infection are associated with high levels of activated CD4 T cells in the cervix uteri
- Predicting tissue graft outcomes using immune markers
- JoAnne Flynn: BCG IV vaccination induces sterilising M.tb immunity.
- Flynn Webinar: What immune cells play a role in protection against M.tb re-infection?
- Flynn Webinar: Immune features associated natural infection
- BCG vaccination reduces infection in the elderly
- Exploratory study investigates the relationship between recent vaccinations and SARS-CoV-2 infection rates.
- Statins: improved survival rates and reduced mortality rate in COVID-19 patients.
- Myeloid-derived suppressor cells: drivers of severe COVID-19 disease?
- Webinar on harnessing innate immunity from cancer therapy to COVID-19
- Uterine NK cell differentiation during the menstrual cycle and pregnancy.
- Global ImmunoTalk on dissecting the interaction of parasites with the immune system
- Researchers may have found a way to “cure” cat allergies?
- The antibody response to SARS-CoV-2 501Y.v2 variant and vaccine implications
- Do mutations in SARS-CoV-2 variants reduce the functional activity of mRNA-vaccine elicited Abs?
- IUIS/Immunopaedia-Frontiers Webinar on Immunoregulation and the tumor microenvironment
- Are current putative COVID-19 vaccines effective against the B.1.351 variants?
- Phase 2a trial provides evidence for potential pancreatic cancer immunotherapy
- COVID-19 is associated with increased MAIT cell activation and cytotoxicity
- Saliva viral load could be a potential correlate of severe COVID-19
- Mutations in SARS-Cov-2 B.1.351 variant reduces vaccine induced Ab neutralisation
- Immuno-metabolism and cognitive decline
- Ad26.COV2.S is safe and immunogenic
- SARS-CoV-2-specific Memory B cells persist up to 8 months post infection.
- Gene editing as a potential sickle cell disease immunotherapy.
- Not all SARS-CoV-2 mutations lead to reduced antibody neutralisation capacity
- Development of a serological diagnostic of Johne’s Disease
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- Lack of interference by type I interferons leads to severe COVID-19
- BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccine efficacy results
- Potential vitiligo immuno-therapeutic: antigen-specific CAR-Tregs
- Vaccine elicitation of engineered HIV-specific B cells: inducing bnAbs
- Which COVID-19 vaccine will be the most effective?
- SARS-CoV-2 serological assay on-a-chip.
- How does SARS-CoV-2 evade the immune defences?
- Investigating Ebola immunity using single cell technologies
- Investigating the role of surfactants during TB using the lung-on-a-chip model
- Gut Inflammation Linked to a Debilitating Skin Condition
- Safety and immunogenicity of Sputnik V vaccine
- SARS-CoV-2 mRNA-1273 vaccine shows signs of potential efficacy
- Pfizer and BioNTech COVID-19 vaccine
- The role of Galectin-3 in the tumor microenvironment
- Developing an oral polio vaccine that does not cause vaccine-associated polio
- Meningeal-IgA+ plasma cells contribute to CNS-immunity
- Should we consider aerosol vaccines for COVID-19
- Testing potential neonatal sepsis drugs using a murine neonatal sepsis.
- Granuloma formation during S.mansoni infection: protective or pathogenic?
- Impact of intermediate hyperglycaemia and diabetes on immune dysfunction in TB
- NIX is essential for systemic metabolic reprogramming of immune cells mediating tuberculosis protection
- NIH COVID-19 lecture on SARS-CoV-2 mRNA vaccine
- Auto-antibody responses to type I IFNs is a clue to severe COVID-19
- Do lipid bodies play a role in innate immunity?
- Trained Immunity in Dogs.
- NIH COVID-19 lecture on SARS-CoV-2 neutralising antibodies
- Why is flu vaccine induced immunity short-lived?
- Molecular mimicry: perfect match propels pathologies
- SAIS/Immunopaedia Webinar: Immunothrombosis & COVID-19
- Safety and immunogenicity of the SARS-CoV-2 mRNA-1273 vaccine candidate in older age.
- Genetically modified Lactococcus lactis- A potential microbial therapeutic for acute colitis?
- IUIS Webinar: Impairment of the immunological and neurological synapses by respiratory viruses
- Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate.
- Why do people with the Dantu blood group have a lower risk of developing malaria?
- Boosting of antibody responses against the V2 and V3 region of the HIV-1 Env
- SAIS/Immunopaedia COVID-19 Webinar on Severe vs mild COVID-19 immunity, and intersection between Nicotinamide pathway & COVID-19.
- A mechanism for severe COVID-19 in patients with obesity and diabetes?
- HIV Viral reservoir: quality rather quantity matters
- We need innovative tools to diagnose Coeliac disease
- IUIS Webinar: Tracking SARS-CoV-2 in Ghana
- Inclusion of non-spike proteins in SARS-CoV-2 vaccines may be important for the induction of protective T cell memory.
- CD229 CAR: New therapy for multiple myeloma
- Immuno-Algeria: Drug hypersensitivity in TB/HIV endemic settings
- SAIS/Immunopaedia Webinar on BCG & COVID-19
- Male and female immune responses to SARS-CoV-2 substantially differ.
- How the Regulator is Regulated: Insight into immune-related Protein holds therapeutic value
- Immuno-Algeria: Non-invasive allergy biomarkers & next-gen immunotherapies
- Are Lung microbial products driving hyperinflammation in severe COVID-19?
- IUIS Webinar: COVID-19 & Immune Compromise
- SARS–CoV-2 infection of the placenta
- Immuno-Algeria: Microbial dysfunction & allergy
- Can saliva be used to test for antibodies to SARS-CoV-2?
- SAIS/Immunopaedia Webinar: COVID-19 Vaccines
- COVID-19 & Multisystem inflammatory syndrome in children
- Do SARS-CoV-2-specific T cells confer long-lived protection?
- Immuno-Algeria: Allergic activity of IgE binding molecules
- Convalescent plasma therapy for COVID-19 is safe.
- IUIS Webinar: Stress dampens anti-viral immunity
- COVID-19 in vitro studies: Use the right cell line
- SAIS/Immunopaedia Webinar: Antibody responses and serology testing
- Immuno-Algeria: IgE & its receptors as a pharmacological targets
- SARS-CoV-2 monoclonal antibodies as potential COVID-19 treatment.
- IUIS Webinar: Predicting survival and severity of COVID-19
- Treating COVID-19 with immunoglobulins, should we be cautious?
- RNA-based vaccine BNT162b1 induces robust IgG and T cell immunity
- IUIS Webinar: Longitudinal COVID-19 Immune Profiling
- Immuno-Algeria 2020: Cellular components of the allergic response
- Tissue tolerance in COVID-19
- Does the D614G mutation in SARS-CoV-2 spike protein result in the virus being more susceptible to neutralization by the host?
- Is blocking inflammatory cell movement using chemokine receptor antagonists the way to go?
- Is there a role of T cells in immune protection to SARS-CoV-2 infection and COVID-19?
- Immuno-Algeria 2020: Introduction to allergy and molecular diagnosis
- Rapid decay of IgG to SARS-CoV-2 in people with mild COVID-19
- The “topology” of the immune response to COVID-19
- IUIS Webinar: Utilising Ramos B cell engineering to measure SARS-CoV-2 Ab responses
- Critically ill COVID-19 patients show evidence for extrafollicular B cell activation
- Immuno-Ethiopia: Xenodiagnosis of Leishmaniasis
- ChAdOx1 nCoV-19 vaccine is safe and immunogenic
- Targeting COVID-19 immunopathology using rapamycin
- Development of a potent SARS-CoV-2 nAb using llamas
- mRNA Vaccine against SARS-CoV-2 induces robust Ab responses
- IUIS Webinar: Seeking correlates of COVID-19 protection and pathology
- Immuno-Ethiopia: Anti-leishmania Immunity
- COVID-19 & GIT symptoms
- IUIS Webinar: COVID-19 Monoclonal Abs
- Aging & COVID-19
- Immuno-Ethiopia: Sand flies & Leishmaniasis
- Innate T cells & severe COVID-19
- Multi-organ damage is a hallmark of severe COVID-19
- IUIS Webinar: COVID-19 in South Africa
- Are polymorphisms in the ACE2 locus important for COVID-19 severity?
- Immuno-Ethiopia: Genetics of Fungal Immunology
- Do mutations in the SARS-CoV-2 spike protein enhances viral infectivity?
- Will the COVID-19 pandemic result in significant neuropsychiatric sequelae?
- IUIS Webinar: Involvement of C5a-C5aR1 axis in COVID-19 pathology
- How effective is Dexamethasone for the treatment of patients with COVID-19?
- SARS-CoV-2-specific IgG and IgM in asymptomatic individuals wane quickly
- Does breast milk contain SARS-CoV-2?
- Are blood groups associated with severe COVID-19 respiratory failure?
- Development of an inactivated vaccine candidate for SARS-CoV-2
- IUIS Webinar: Understanding Infection and Immunity of SARS-CoV-2
- IUIS Webinar: Respiratory Immunity and COVID-19
- Identification of two B cell epitopes that induce neutralising Ab in COVID-19 patients
- COVID-19 vaccines: can alum based adjuvants improve induction of nAbs?
- What evidence is there for pre-existing antibody responses to SARS-CoV-2?
- Is COVID-19 an endothelial disease?
- A recombinant adenovirus type-5 vectored COVID-19 vaccine appears safe and immunogenic in a first-in-human trial.
- SARS-CoV-2 monkey model shows protection from re-infection.
- An exuberant inflammatory host response to SARS-CoV-2 leads to COVID-19.
- IUIS Webinar: Role of cellular responses in COVID-19
- SARS-CoV-2 infection in young children and Kawasaki-like disease.
- No evidence that BCG vaccination can protect against SARS-CoV-2 infection.
- Do we have more T cell immunity to SARS-CoV-2 than we think?
- Is the rapid generation of neutralizing antibodies to SARS-CoV-2 good news for preventing reinfection?
- The current status of COVID-19 immunology
- IUIS Webinar: Trained immunity and BCG vaccination: a tool against COVID-19?
- A nail in the coffin of (hydro)chloroquine treatment against COVID-19?
- SARS-CoV-2 found in semen.
- Can anti-HIV drugs, Lopinavir and Ritonavir, be used to treat patients with severe COVID-19?
- Can the Cytokine Release Syndrome in COVID-19 patients be treated using CCR5 blocking antibody therapy?
- IUIS Webinar: Adaptive Immunity in COVID-19
- Can a Chimpanzee vector vaccine prevent SARS-CoV-2 pneumonia?
- Getting to the guts of SARS-CoV-2 infection
- Cigarette smoke triggers increased ACE-2 expression in the lung
- Respiratory disease and viral shedding in rhesus macaques inoculated with SARS-CoV-2
- IUIS Webinar: What cancer immunologists are doing about COVID-19 ?
- BCG induced trained immunity & COVID-19
- Is there a SARS-CoV-2 receptor (ACE2) expression difference between males and females?
- Roles of different anti-SARS-CoV-2 antibodies in COVID-19 disease and protection
- Exaggerated immune response to Covid-19
- Can neonates born to mothers with COVID-19 acquire maternal infection ?
- Mutation in the Spike protein may explain higher infectivity of SARS-CoV-2 and accelerated disease.
- IUIS Webinar: Global outbreaks – Interferons as 1st responders
- An inventory of the vaccine candidates to SARS-CoV-2
- COVID-19: extending or relaxing distancing control measures
- Is a self-amplifying RNA SARS-CoV-2 lipid nanoparticle a good vaccine candidate?
- SARS-CoV-2 transmission exploits existing secretory pathways in the nasal cavity: a vaccine/drug target?
- The role of complement in COVID-19 pathogenesis.
- Scientific Response to COVID-19 Video
- Can two FDA-approved drugs be re-purposed to clear SARS-CoV-2 infection?
- Should we consider SARS-CoV-2 human challenge models for vaccine testing ?
- Mask wearing to reduce the spread of COVID-19
- Development of inactivated SARS-CoV-2 vaccines
- Cytokine Release Syndrome & COVID-19
- COVID-19 Antibody Immunology Video
- Uncertainty is hampering doctors’ ability to treat COVID-19
- Detection of SARS-CoV-2 nAbs in cats
- Susceptibility of domestic animals to SARS-Cov-2
- Indian population could have intrinsic immunity to resist COVID-19 challenge
- Viral dynamics in mild vs severe COVID-19
- SARS-CoV-2 transmission and mask wearing.
- Convalescent sera option for containing COVID-19
- Potential SARS-CoV-2 & COVID-19 Vaccines
- COVID-19 Vaccinology Videos
- Chloroquine treatment and COVID-19
- Exhaustion of antiviral NK and CD8 T cells in SARS-CoV-2 infection
- The different clinical characteristics of COVID-19 between children and adults.
- Safety considerations in laboratory practice when testing specimens from patients suspected or infected with SARS-CoV-2
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- Where did SARS-CoV-2 come from?
- Faecal shedding of SARS-CoV-2
- COVID-19 spurs interest in preprints and improves scientific collaboration
- BCG & COVID-19
- Potent neutralizing antibodies isolated from COVID-19 patients
- The potential benefit of high-dose intravenous Ig in severe COVID-19
- SOLIDARITY TRIAL: Testing existing drugs to treat COVID-19
- Why is COVID-19 so mild in children?
- SOLIDARITY TRIAL: WHO COVID-19 treatment trial
- Could blood groups influence COVID-19 disease severity?
- Why are hypertension and diabetes patients at high risk of severe COVID-19?
- The Origin of SARS-CoV-2
- Does COVID-19 have a seasonal pattern?
- Broad-spectrum Antiviral Inhibits SARS-CoV-2
- Hypothetical pathogenesis of SARS-CoV-2 infection in humans
- COVID-19 – Cytokine storm syndromes and immunosuppression
- WORLD TB DAY: COVID-19 & TB
- Kinetics of Immune Response in a Mild COVID-19 Patient
- Immuno-Ethiopia: Fungal epidemiology and immunology
- Immuno-Ethiopia: Malaria Highlight 2
- Immuno-Ethiopia: Malaria Highlight 1
- Single-cell RNA-Seq of BAL samples from COVID-19 patients
- Type I interferon co-stimulation of MAIT cell function
- The (Un)usual Suspect-Novel Coronavirus Identified
- Murine model of coeliac disease
- miRNA carried by NETs modulate macrophage function
- Does mumps immunity induced by 2 doses of MMR wane in adulthood?
- Fever: A positive regulator of Th17 mediated inflammation
- T cells altered by CRISPR may be safe to use in cancer patients
- DENV-infection induces two major CD8 T cell memory subsets
- Repurposing of a drug for alcoholism to treat cancer
- Measles induced immunological amnesia
- SEPSIS is WANTED!
- Discovery of novel cancer signalling mechanism
- Macrophages and Cervical Cancer: What’s going on with the microenvironment ?
- How DNA outside cells can be targeted to prevent the spread of cancer
- Solving the puzzle of IgG4-related disease, the elusive autoimmune
- How the rice blast fungus “eats” its own cell wall to launch an attack
- Can intravenous-BCG prevent M.tb infection ?
- How does group A Streptococcus evade immunity?
- TB biomarker based on anti-Ag85B and 4 inflammatory molecules.
- Immuno-Jaipur Highlight: Primary immunodeficiencies
- Immuno-Jaipur Highlight: Clinical viral immunity
- Immuno-Jaipur Highlight: MHC and Transplantation Immunology
- Immuno-Jaipur Highlight : Part 2 of Day 4
- Immuno-Jaipur Highlight : Day 4
- Immuno-Jaipur Highlight: Part 2 of Day 3
- Immuno-Jaipur Highlight of talks by Abul Abbas
- Immuno-Jaipur Highlight: Insights into innate and adaptive immunity
- IUIS-IIS-FIMSA-Immuno-Jaipur Report
- IUIS Beijing ICI 2019
- IDA Highlight: What’s New in anti-HIV humoral immunity.
- IDA Highlight: Current state of malaria vaccines
- IDA Highlight: Scanning the TCR repertoire to inform new TB vaccine targets
- IDA Highlight: Possible barriers and opportunities for HIV cure
- IDA Highlight: Not all levels of malaria exposure induce the same anti-malarial immunity
- IDA Highlight: Immune responses to TB vaccines
- IDA Highlight: CD4 T cells in HIV infection
- Career Advice from IDA faculty that were once previous IDA Scholars
- Lipid profiles key step to preventing breast cancer metastasis through epithelial-mesenchymal transition
- The Vaccinology course, if you are in the vaccine-world, you shouldn´t miss it!
- Investigating the immunological composition of the Kidney
- CD27 expression identifies Th17 cells with high stemness properties
- New fungus-derived antibiotic: relief in sight for immunocompromised people
- HIV RV144 vaccine induces better responses in SA compared to Thailand
- Rethinking HIV remission strategies: end of the road for anti-α4β7 ?
- GLA-SE promotes superior Tfh expansion than Alum
- Class-switch recombination of antibodies occurs prior to germinal center formation.
- Can anti-α4β7 really “cure” SIV infection in ART interrupted NHPs ?
- New insights into the role of HPV oncoproteins and immune response in cervical cancer
- Did you know neutrophils can help to form gallstones?
- Can vaccinating cats against their own proteins reduce cat allergies in humans?
- Use of future liposomal cancer oncology treatment
- What other disease affect individuals with olive pollen allergies?
- The Immune Function of Osteoclasts
- TAK-003 induces functional DENV cross-reactive cellular immmunity
- Wild is better: in-bred mice born to wild mice resemble human responses
- Do NK cells play an important role in anti-Trypanosomiasis immunity?
- Are MAIT cells detectable in lymph?
- Does S. mansoni treatment affect HIV susceptibility?
- Investigating the HIV viral reservoir during acute infection
- How does BCG affect early innate immune responses?
- Sex associated differences to flu vaccination: role of estradiol?
- Propagation of α-synuclein from the gut to brain – new causation for Parkinson’s disease?
- Have you heard of Mycetoma ?
- How does plasmodial hemozoin contribute to cerebral malaria pathogenesis?
- Are neutrophils in the tumor microenvironment friend or foe?
- Animal models to measure mucosal innate immunity: zebrafish vs mice.
- Development of natural murine model of Cryptosporidiosis
- Does whole cell pertussis vaccination skew infection induced Ab profiles?
- Is Yellow fever vaccination safe for HIV+ individuals?
- The emerging role of IL-26 in fighting against intracellular microbes
- T cell activation as a potential surrogate marker for TB treatment efficacy.
- Does HIV-env vaccination strategy affect the recognition pattern of IgG responses?
- Does dysbiosis of the GIT microbiome enhance the neutrophils survival and chronic inflammation in HIV+ individuals?
- Dual BCR and TCR co-expressing lymphocyte could play a role in T1D pathogenesis.
- M.tb resistors: M.tb uninfected or atypical IFN-𝛾-independent M.tb immune responses ?
- Course Highlight: 5th Vaccinology in Course
- Immunoinformatics Mexico 2019: Immunologic plasticity, defense lines.
- Immunoinformatics Mexico 2019: Part Two
- Immunoinformatics Mexico 2019: Part One
- Aiding Tuberculosis vaccine studies with the use of a mycobacterial growth inhibition assay
- Further Support of the Emerging “Immunologic” Hypothesis in Mood and Eating Disorders
- Immunopaedia goes to the XIII World Immune Regulation Meeting
- Evolution of flu-vaccine induced B cell responses
- Antiviral pathways induced in the RV144 vaccine trial
- How are CD8 responses against the malaria liver stage antigens primed ?
- Contributions to the understanding of the cellular immune response elicited by Brucella canis
- IL-7Rαlo KLRG1hi cells are not always short lived effector cells
- Dual bNAb therapy can maintain HIV viral suppression
- A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours?
- Targeting the metabolic profile of latently infected macrophages as a potential treatment for HIV
- PD-1/PDL1 pathway in the maintenance of maternal-foetal immunotolerance
- How does the complement cascade result in pore formation in Lampreys
- HIV complications: inflamma-aging or increased activation ?
- Does BCG improve de novo malaria immunity ?
- Hematopoietic stem cell transplantation cures HIV
- Do neutrophils play a role in age-associated increase in flu mortality?
- Do NK cells play a role in vaccine induced humoral immunity ?
- ICOS: is it essential for Treg-IL10 expression in the colon?
- How does IL-27 attenuate autoimmune neuroinflammation?
- CNS-neuroinflammation: not all myeloid cells are responsible
- Immunosenescence: how does it affect vaccine Ab responses ?
- Recurrent Strep throat: when TFH cells “turn on” you
- TB episode following PD-1 blockade
- Can a vaccine prevent ZIKV associated fetal abnormalities ?
- Does mucosal BCG vaccination induce “protective” immunity ?
- Are CD8+ and DN MAIT cells distinct populations ?
- What can ZIKV-CD8 T cells do ?
- Can some Tfh cells produce IFN-𝛾 ?
- Have you heard of the ESAT-6 free IGRA ?
- Are distinct monocyte subsets associated with severe Chagas diseases?
- Does HIV superinfection induce an additive or synergistic Ab effect?
- Where do memory B cells get reactivated?
- Strain specific host restriction of recurrent UTIs
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014